Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00606164
What this trial is testing

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Blanchette Rockefeller Neurosciences Insitute 9
Testing effectiveness (Phase 2)Study completedNCT01723826
What this trial is testing

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 360
Testing effectiveness (Phase 2)Study completedNCT02756858
What this trial is testing

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 21
Not applicableLooking for participantsNCT05295615
What this trial is testing

Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Herrick Medical LLC 40
Early research (Phase 1)Study completedNCT02353598
What this trial is testing

Crenezumab in Participants With Mild to Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Genentech, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT02947893
What this trial is testing

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Georgetown University 37
Testing effectiveness (Phase 2)Study completedNCT05363293
What this trial is testing

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

Who this might be right for
Alzheimer's DiseaseHealthy Non-elderly and Elderly Adults
Alzamend Neuro, Inc. 65
Early research (Phase 1)Study completedNCT00607308
What this trial is testing

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 20
Early research (Phase 1)Study completedNCT02386306
What this trial is testing

Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GliaCure, Inc. 39
Not applicableNot Yet RecruitingNCT07658430
What this trial is testing

Deep Cervical Lymphovenous Anastomosis for Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Southwest Hospital, China 296
Not applicableLooking for participantsNCT05926011
What this trial is testing

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
REGEnLIFE SAS 108
Large-scale testing (Phase 3)UnknownNCT01282619
What this trial is testing

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shandong Luye Pharmaceutical Co., Ltd. 390
Not applicableStudy completedNCT01825330
What this trial is testing

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Neuronix Ltd 131
Not applicableStudy completedNCT06681948
What this trial is testing

The Ketogenic Diet in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Capital Medical University 32
Early research (Phase 1)Study completedNCT00397891
What this trial is testing

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 80
Large-scale testing (Phase 3)Study completedNCT01741194
What this trial is testing

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

Who this might be right for
Alzheimer's Disease
Cerecin 418
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Testing effectiveness (Phase 2)Study completedNCT01453569
What this trial is testing

Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCognitive Impairment
Shanghai Greenvalley Pharmaceutical Co., Ltd. 255
Post-approval studies (Phase 4)UnknownNCT00866060
What this trial is testing

Donepezil and Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer's Disease
King's College London 800
Not applicableStudy completedNCT02210286
What this trial is testing

Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia

Who this might be right for
DementiaAlzheimer's Disease
Stanford University 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation